Global medical reit inc.GMRE-PA.US Overview

GMRE-PA Earnings Table

• When is GMRE-PA's latest earnings report released?

  The most recent financial report for Global medical reit inc. (GMRE-PA) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating GMRE-PA's short-term business performance and financial health. For the latest updates on GMRE-PA's earnings releases, visit this page regularly.

• Where does GMRE-PA fall in the P/E River chart?

  According to historical valuation range analysis, Global medical reit inc. (GMRE-PA)'s current price-to-earnings (P/E) ratio is -9.57, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

• How is GMRE-PA's revenue growth?

  In the latest financial report, Global medical reit inc. (GMRE-PA) announced revenue of 35.17M, with a Year-Over-Year growth rate of 0.63%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

• How much cash does GMRE-PA have?

  At the end of the period, Global medical reit inc. (GMRE-PA) held Total Cash and Cash Equivalents of 9.08M, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

• Is GMRE-PA's EPS continuing to grow?

  According to the past four quarterly reports, Global medical reit inc. (GMRE-PA)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.55. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

• What is the FCF of GMRE-PA?

  Global medical reit inc. (GMRE-PA)'s Free Cash Flow (FCF) for the period is -88M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 163.91% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

• What are the PEG ratio and PE ratio of GMRE-PA?

  The latest valuation data shows Global medical reit inc. (GMRE-PA) has a Price-To-Earnings (PE) ratio of -9.57 and a Price/Earnings-To-Growth (PEG) ratio of -0.43. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.